Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-02

Clinical Trial Update: ADAPT - A Patient Registry of the Real-world Use of Orenitram®

View source ↗

Summary

ADAPT is a patient registry tracking real-world use of Orenitram for pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orenitram (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Status: ACTIVE_NOT_RECRUITING